Market Place
Company
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
X
Developments Pulmonary/Respiratory Diseases Discovery
Details:
Under the terms of the agreement, Moderna will lead discovery efforts, leveraging its leading mRNA technology and delivery platforms along with Chiesi’s expertise in the field of PAH biology.
Lead Product(s): mRNA Therapeutics
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Chiesi Group
Deal Size: $425.0 million Upfront Cash: $25.0 million
Deal Type: Collaboration September 16, 2020
Details:
The partnership will leverage Recursion’s purpose-built-AI-guided drug discovery platform and Bayer’s small molecule compound library and deep scientific expertise to discover and develop new treatments for fibrotic diseases of the lung, kidney, heart and more.
Lead Product(s): Undisclosed
Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Small molecule
Partner/Sponsor/Collaborator: Bayer AG
Deal Size: $1,030.0 million Upfront Cash: $30.0 million
Deal Type: Collaboration September 09, 2020
